BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11320901)

  • 1. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J; Kvasnicka HM; Boeltken B; Zankovich R; Diehl V; Fischer R
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification.
    Thiele J; Kvasnicka HM; Fischer R
    Ann Hematol; 1999 Nov; 78(11):495-506. PubMed ID: 10602893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Leuk Lymphoma; 2002 May; 43(5):1035-41. PubMed ID: 12148883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders--a clue to diagnosis and classification.
    Thiele J; Kvasnicka HM
    Pathol Biol (Paris); 2001 Mar; 49(2):140-7. PubMed ID: 11317959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ
    Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?
    Thiele J; Kvasnicka HM; Diehl V
    Histol Histopathol; 2005 Apr; 20(2):633-44. PubMed ID: 15736066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
    Thiele J; Kvasnicka HM; Diehl V; Fischer R; Michiels J
    Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
    Michiels JJ
    Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2003 Jan; 18(1):93-102. PubMed ID: 12507288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zankovich R; Diehl V
    Am J Hematol; 2002 Aug; 70(4):283-91. PubMed ID: 12210809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
    Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
    Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
    Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.